These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 2183630)

  • 21. Antidepressants and somatic symptoms: therapeutic actions are expanding beyond affective spectrum disorders to functional somatic syndromes.
    Stahl SM
    J Clin Psychiatry; 2003 Jul; 64(7):745-6. PubMed ID: 12934972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnosis and treatment of mood disorders that co-occur with schizophrenia.
    Escamilla MA
    Psychiatr Serv; 2001 Jul; 52(7):911-9. PubMed ID: 11433108
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Maintenance treatment with antidepressants in panic disorder.
    Noyes R; Perry P
    J Clin Psychiatry; 1990 Dec; 51 Suppl A():24-30. PubMed ID: 2258373
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A case series on the hypothesized connection between dementia and bipolar spectrum disorders: bipolar type VI?
    Ng B; Camacho A; Lara DR; Brunstein MG; Pinto OC; Akiskal HS
    J Affect Disord; 2008 Apr; 107(1-3):307-15. PubMed ID: 17889374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mood disorders in restless legs syndrome (Willis-Ekbom disease).
    Becker PM; Sharon D
    J Clin Psychiatry; 2014 Jul; 75(7):e679-94. PubMed ID: 25093484
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New trends in the neurobiology and pharmacology of affective disorders.
    LasoĊ„ W; Budziszewska B; Basta-Kaim A; Kubera M; Maes M
    Pharmacol Rep; 2013; 65(6):1441-50. PubMed ID: 24552991
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy.
    Akiskal HS; Benazzi F; Perugi G; Rihmer Z
    J Affect Disord; 2005 Apr; 85(3):245-58. PubMed ID: 15780694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Putative mechanisms of action of antidepressant drugs in affective and anxiety disorders and pain.
    Blier P; Abbott FV
    J Psychiatry Neurosci; 2001 Jan; 26(1):37-43. PubMed ID: 11212592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anxious depression.
    Lydiard RB; Brawman-Mintzer O
    J Clin Psychiatry; 1998; 59 Suppl 18():10-7. PubMed ID: 9840193
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utilization of antidepressants in Taiwan: a nationwide population-based survey from 2000 to 2009.
    Wu CS; Shau WY; Chan HY; Lee YC; Lai YJ; Lai MS
    Pharmacoepidemiol Drug Saf; 2012 Sep; 21(9):980-8. PubMed ID: 22511574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacologic treatment of anxiety disorders.
    Mavissakalian M
    J Clin Psychiatry; 1982 Dec; 43(12):487-91. PubMed ID: 6131065
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetic and pharmacodynamic drug interactions with polypharmacotherapy of treatment-resistant affective and obsessive-compulsive disorders.
    Carson SW
    Psychopharmacol Bull; 1996; 32(4):555-68. PubMed ID: 8993076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential response patterns to MAO inhibitors and tricyclics.
    Nies A
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):70-7. PubMed ID: 6376487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antidepressant drugs and cytokines in mood disorders.
    Nishida A; Hisaoka K; Zensho H; Uchitomi Y; Morinobu S; Yamawaki S
    Int Immunopharmacol; 2002 Nov; 2(12):1619-26. PubMed ID: 12469936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. History and evolution of the monoamine hypothesis of depression.
    Hirschfeld RM
    J Clin Psychiatry; 2000; 61 Suppl 6():4-6. PubMed ID: 10775017
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination therapy with monoamine oxidase inhibitors and other antidepressants or stimulants: strategies for the management of treatment-resistant depression.
    Thomas SJ; Shin M; McInnis MG; Bostwick JR
    Pharmacotherapy; 2015 Apr; 35(4):433-49. PubMed ID: 25884531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modifications of the serotonin system by antidepressant treatments: implications for the therapeutic response in major depression.
    Blier P; de Montigny C; Chaput Y
    J Clin Psychopharmacol; 1987 Dec; 7(6 Suppl):24S-35S. PubMed ID: 3323264
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does depression screening have an effect on the diagnosis and treatment of mood disorders in general medical settings?: an instrumental variable analysis of the national ambulatory medical care survey.
    Mojtabai R
    Med Care Res Rev; 2011 Aug; 68(4):462-89. PubMed ID: 21454246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapy of affective disorders.
    Alexander B; Cook B
    Prim Care; 1990 Sep; 17(3):565-88. PubMed ID: 2236337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fluoxetine: a spectrum of clinical applications and postulates of underlying mechanisms.
    Messiha FS
    Neurosci Biobehav Rev; 1993; 17(4):385-96. PubMed ID: 8309648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.